Cancers · 2021 · 34 citations · 33 references
MedicineOncologyPharmacologyCancer PharmacologyCellular PharmacologyMolecular OncologyCannabinoid PharmacologyCentral Nervous System Tumor PharmacotherapyCytotoxicity AssessmentGlioblastomaOncology PharmacologyCannabinoid Structure-activity RelationshipsCell Cycle InhibitionGas Chromatography-mass SpectrometryGlioblastoma Stem CellsHigh-performance Liquid ChromatographyHigh-performance Liquid Chromatography ProfilingLactate Dehydrogenase Release AssaysLiquid Chromatography-mass Spectrometry
, among them Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) that trigger GBM cell death. However, the optimal combinations of cannabis molecules for anti-GBM activity are unknown. Chemical composition was determined using high-performance liquid chromatography (HPLC) and gas chromatography mass spectrometry (GC/MS). Cytotoxic activity was determined by XTT and lactate dehydrogenase (LDH) assays and apoptosis and cell cycle by fluorescence-activated cell sorting (FACS). F-actin structures were observed by confocal microscopy, gene expression by quantitative PCR, and cell migration and invasion by scratch and transwell assays, respectively. Fractions of a high-THC cannabis strain extract had significant cytotoxic activity against GBM cell lines and glioma stem cells derived from tumor specimens. A standard mix (SM) of the active fractions F4 and F5 induced apoptosis and expression of endoplasmic reticulum (ER)-stress associated-genes. F4 and F5 inhibited cell migration and invasion, altered cell cytoskeletons, and inhibited colony formation in 2 and 3-dimensional models. Combinations of cannabis compounds exert cytotoxic, anti-proliferative, and anti-migratory effects and should be examined for efficacy on GBM in pre-clinical studies and clinical trials.
33
Identification of a cancer stem cell in human brain tumors.
Sheila K. Singh, Ian D. Clarke, Mizuhiko Terasaki et al. · PubMed · 2003 · 4.9K citations
Medicine, Cell Biology, Oncology +17
Isolation of cancer stem cells from adult glioblastoma multiforme
Xiangpeng Yuan, James F. Curtin, Yizhi Xiong et al. · Oncogene · 2004 · 790 citations · Full text
Medicine, Cell Biology, Oncology +14